CD4 and myeloid sarcoma: Furthermore, the upregulation of miR-223 in CD4+ T cells of MS patients and EAE models [29], a greater degree of miR-223 in PBMCs from MS patients correlated with healthy people [30], as well as a higher rank of miR-223 in active MS lesions compared to normal CNS areas in healthy subjects, was recently published by another group in accordance with our findings [31].